A61K 31/737
Sulfated polysaccharides
Official title: Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate (A61K31/727 takes precedence)
A61K31/737 (Sulfated polysaccharides) appears on 652 US grants and 1,197 published applications in this corpus.
Search patents in A61K- Granted patents
- 652
- Published applications
- 1,197
- Assignees
- 601
- Inventors
- 1,925
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 13 | 0 |
| 1998 | 14 | 0 |
| 1999 | 16 | 0 |
| 2000 | 13 | 0 |
| 2001 | 8 | 8 |
| 2002 | 12 | 24 |
| 2003 | 15 | 47 |
| 2004 | 11 | 44 |
| 2005 | 10 | 57 |
| 2006 | 16 | 62 |
| 2007 | 8 | 42 |
| 2008 | 6 | 30 |
| 2009 | 9 | 41 |
| 2010 | 22 | 37 |
| 2011 | 19 | 43 |
| 2012 | 21 | 40 |
| 2013 | 35 | 67 |
| 2014 | 40 | 62 |
| 2015 | 27 | 56 |
| 2016 | 34 | 55 |
| 2017 | 34 | 54 |
| 2018 | 31 | 41 |
| 2019 | 38 | 45 |
| 2020 | 26 | 56 |
| 2021 | 34 | 67 |
| 2022 | 33 | 44 |
| 2023 | 23 | 60 |
| 2024 | 23 | 45 |
| 2025 | 29 | 31 |
| 2026 | 16 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Low endotoxin fucan compositions, systems and methods25 Aug 2026US 12,714,724 B2ARC Medical Inc.
- Antiviral agents for prevention or treatment of pathologies caused by alpha- and/or beta-coronaviruses28 Jul 2026US 12,691,139 B2Fidia Farmaceutici S. P. A.
- Treatment of sepsis and hypercytokinemia7 Jul 2026US 12,673,070 B2Tx Medic AB
- CXCL8 inhibitors for use in the treatment of COVID-1926 May 2026US 12,636,268 B2Dompé Farmaceutici S.P.A.
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions26 May 2026US 12,636,308 B2Adora Animal Health Corporation
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Composition comprising homogeneous polysaccharide or derivative thereof and method of using the same to prevent and/or treat bone loss8 Oct 2026US 2026/0306529 A1
- Microbiome-based GABA Cream with Chondroitin Sulfate Transdermal Delivery System8 Oct 2026US 2026/0306531 A1
- Use of sulfated gluco-galactooligosaccharide in preparation of drugs for treating atopic dermatitis24 Sep 2026US 2026/0284100 A1Nanjing University of Science and Technology
- Irritation relieving agent, method for producing the same, and external skin preparation24 Sep 2026US 2026/0284101 A1Refine Holdings Co., Ltd.
Most cited
By later US patents
- Composition and method for the repair and regeneration of cartilage and other tissues193US 7,148,209 B2Ecole Polytechnique · 2006
- Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate137US 5,605,938 AGliatech, Inc. · 1997
- Delivery of agents and method for regeneration of periodontal tissues128US 6,123,957 A2000
- Pharmaceutical compositions containing orally absorbable glycosamimoglycans119US 5,252,339 AAlfa Wasserman S.p.A. · 1993
- Injectable medical composition and method of use119US 5,639,796 AC. R. Bard, Inc. · 1997